biOasis Technologies Inc
OTC:BIOAF

Watchlist Manager
biOasis Technologies Inc Logo
biOasis Technologies Inc
OTC:BIOAF
Watchlist
Price: 0.0002 USD
Market Cap: 10k USD

Profitability Summary

biOasis Technologies Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
biOasis Technologies Inc

Revenue
269.4k CAD
Operating Expenses
-3.3m CAD
Operating Income
-3.1m CAD
Other Expenses
198.2k CAD
Net Income
-2.9m CAD

Margins Comparison
biOasis Technologies Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
CA
biOasis Technologies Inc
XTSX:BTI
10k CAD
-1 141%
-1 068%
IL
Can Fite Biopharma Ltd
TASE:CANF
157.8T ILS
-1 487%
-1 456%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
382.8B USD
33%
4%
US
Amgen Inc
NASDAQ:AMGN
172.7B USD
34%
19%
US
Gilead Sciences Inc
NASDAQ:GILD
150B USD
39%
28%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
39%
31%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
-392%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
28%
32%
AU
CSL Ltd
ASX:CSL
83.9B AUD
26%
19%
NL
argenx SE
XBRU:ARGX
42.2B EUR
22%
43%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
biOasis Technologies Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
biOasis Technologies Inc
XTSX:BTI
10k CAD
135%
-121%
396%
581%
IL
Can Fite Biopharma Ltd
TASE:CANF
157.8T ILS
-383%
-187%
-273%
-6 189%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
382.8B USD
139%
2%
20%
28%
US
Amgen Inc
NASDAQ:AMGN
172.7B USD
82%
8%
17%
15%
US
Gilead Sciences Inc
NASDAQ:GILD
150B USD
41%
14%
25%
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.5B USD
22%
16%
23%
25%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
15%
12%
11%
12%
AU
CSL Ltd
ASX:CSL
83.9B AUD
16%
8%
12%
10%
NL
argenx SE
XBRU:ARGX
42.2B EUR
30%
26%
15%
62%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less